Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Thursday, June 5, 2008

Genocea and PATH collaborate on pneumococcal vaccine

By Mass High Tech Staff


Vaccine development company Genocea Biosciences Inc. has teamed up with global nonprofit PATH and Richard Malley, associate professor of pediatrics at Children’s Hospital Boston, to develop a new Streptococcus pneumoniae vaccine for particular use in developing countries. The collaboration involves research on “common protein” vaccines that could have widespread impact, according to Genocea officials.

PATH is a Seattle-based nonprofit dedicated to improving global health.

Malley is a leader in pneumococcus immunization and has served as principal investigator of a 2006 PATH project for developing whole-cell pneumococcal vaccine for children.

All three collaborators will participate in the 6th International Symposium on Pneumococci & Pneumococcal Diseases June 8-12 in Reykjavik, Iceland.

Genocea Biosciences was founded in 2006 and is based on developments from the University of California at Berkeley and Harvard Medical School. It uses a high-speed screening system that can identify which of a disease’s thousands of proteins, or antigens, would elicit an immune response in humans.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

What's your level of interest in Pinterest?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.